-
公开(公告)号:US5998153A
公开(公告)日:1999-12-07
申请号:US313200
申请日:1994-11-08
IPC分类号: A61K38/00 , A61K39/00 , C12N9/08 , G01N33/564 , G01N33/573 , A61K38/43
CPC分类号: C12N9/0065 , G01N33/564 , G01N33/573 , A61K38/00 , A61K39/00 , G01N2800/24 , Y10S435/975 , Y10S436/811 , Y10S530/854
摘要: Specific epitopic regions of thyroid peroxidase (TPO), a thyroid specific membrane autoantigen, have been identified within amino acid residues 456 to 933, 517 to 630, and 633 to 933 of the protein (SEQ ID NO:1), with at least one distinct binding region within TPO located from amino acid residues 592 to 613 (SEQ ID NO:3). The identification and production of these localized epitopes/epitopic regions provide specific diagnostic reagents for autoimmune thyroid disease.
摘要翻译: PCT No.PCT / US93 / 03837 Sec。 371日期:1994年11月8日 102(e)日期1994年11月8日PCT提交1993年4月22日PCT公布。 公开号WO93 / 23073 日期1997年11月25日已经在蛋白质(SEQ ID NO:1)的456至933,517至630和633至933的氨基酸残基内鉴定了甲状腺过氧化物酶(TPO),甲状腺特异性膜自身抗原的特异性表位区域, ,在TPO内至少有一个与氨基酸残基592至613(SEQ ID NO:3)不同的结合区。 鉴定和产生这些局部表位/表位区为自身免疫性甲状腺疾病提供了特异性的诊断试剂。
-
公开(公告)号:US5919442A
公开(公告)日:1999-07-06
申请号:US694787
申请日:1996-08-09
申请人: Rui Yin , Donald A. Tomalia , David M. Hedstrand , Douglas R. Swanson , James R. Baker, Jr. , Jolanta F. Kukowska-Latallo
发明人: Rui Yin , Donald A. Tomalia , David M. Hedstrand , Douglas R. Swanson , James R. Baker, Jr. , Jolanta F. Kukowska-Latallo
IPC分类号: A61K8/90 , A61K31/74 , A61K47/48 , A61K48/00 , A61K49/00 , A61K51/02 , A61Q13/00 , C08G83/00 , C12N15/87 , A01N25/10
CPC分类号: A61Q13/00 , A61K47/48169 , A61K47/48176 , A61K47/48192 , A61K47/482 , A61K47/48207 , A61K47/4823 , A61K47/48253 , A61K47/487 , A61K47/48961 , A61K49/0043 , A61K49/0054 , A61K8/90 , B82Y5/00 , C08G83/005 , C12N15/87 , A61K2800/54 , A61K2800/57 , A61K48/00 , Y10S424/16 , Y10S525/902
摘要: A novel class of hyper comb-branched polymers conjugated with carried materials are disclosed.
摘要翻译: 公开了一种与携带材料共轭的新型超梳状支化聚合物。
-
公开(公告)号:US10206996B2
公开(公告)日:2019-02-19
申请号:US13591775
申请日:2012-08-22
申请人: Ali I. Fattom , Jakub Simon , James R. Baker, Jr. , Tarek Hamouda , Vira Bitko
发明人: Ali I. Fattom , Jakub Simon , James R. Baker, Jr. , Tarek Hamouda , Vira Bitko
IPC分类号: A61K39/00 , A61K39/245 , A61K39/39 , A61K9/107 , A61K39/12
摘要: The present application relates to the field of human immunology, in particular, a herpes simplex virus (HSV) vaccine. The subunit vaccine composition comprises isolated surface glycoproteins from herpes simplex viruses, fusion proteins or fragments thereof mixed in varied combination with a nanoemulsion, which is a potent immune enhancer.
-
24.
公开(公告)号:US09561271B2
公开(公告)日:2017-02-07
申请号:US13608317
申请日:2012-09-10
申请人: Ali I. Fattom , Tarek Hamouda , Vira Bitko , James R. Baker, Jr.
发明人: Ali I. Fattom , Tarek Hamouda , Vira Bitko , James R. Baker, Jr.
IPC分类号: A61K39/155 , A61K9/107 , A61K47/10 , A61K47/18 , A61K47/26 , A61K47/44 , A61K39/12 , A61K39/00
CPC分类号: A61K39/155 , A61K9/1075 , A61K39/12 , A61K47/10 , A61K47/186 , A61K47/26 , A61K47/44 , A61K2039/5252 , A61K2039/543 , A61K2039/55555 , A61K2039/55566 , C12N2760/18034
摘要: The present application relates to the field of immunology, in particular, a vaccine composition of respiratory syncytial virus (RSV) surface proteins, Fusion (F) and Glycoprotein (G) proteins subunit vaccine preferentially mixed with the immune cell targeting and enhancer, nanoemulsion to induce a protective immune response and avoid vaccine-induce disease enhancement.
摘要翻译: 本申请涉及免疫学领域,特别是呼吸道合胞病毒(RSV)表面蛋白,融合(F)和糖蛋白(G)蛋白亚基疫苗的疫苗组合物优先与免疫细胞靶向和增强子混合,纳米乳剂 诱导保护性免疫应答,并避免疫苗诱导疾病增强。
-
公开(公告)号:US09144606B2
公开(公告)日:2015-09-29
申请号:US12427517
申请日:2009-04-21
IPC分类号: A61K39/145 , C07K14/005 , C12N7/00 , A61K9/107 , A61K39/00 , A61K39/12
CPC分类号: A61K39/145 , A61K9/0014 , A61K9/0043 , A61K9/1075 , A61K39/00 , A61K39/12 , A61K39/39 , A61K2039/5252 , A61K2039/54 , A61K2039/543 , A61K2039/545 , A61K2039/55566 , A61K2039/58 , A61K2039/70 , C07K14/005 , C12N7/00 , C12N2760/16134 , C12N2760/16171 , C12N2760/16234 , C12N2760/16271
摘要: The present invention relates to methods for inducing an immune response to influenza in a subject comprising administering a nanoemulsion vaccine composition comprising an influenza immunogen or protein.
摘要翻译: 本发明涉及在受试者中诱导针对流感的免疫应答的方法,包括施用包含流感免疫原或蛋白质的纳米乳剂疫苗组合物。
-
公开(公告)号:US08877208B2
公开(公告)日:2014-11-04
申请号:US12472218
申请日:2009-05-26
申请人: James R. Baker, Jr. , Paul E. Makidon , Nicholas J. Mank , Anna U. Bielinska , Luz P. Blanco , Jessica Knowlton
发明人: James R. Baker, Jr. , Paul E. Makidon , Nicholas J. Mank , Anna U. Bielinska , Luz P. Blanco , Jessica Knowlton
IPC分类号: A61K39/116 , A01N63/00 , A61K45/00 , A61K39/00 , A61K39/38 , A61K39/02 , A61K39/08 , A61K39/07 , A61K9/107 , A61K39/29 , A61K39/39
CPC分类号: A61K9/0043 , A61K9/107 , A61K9/1075 , A61K39/0291 , A61K39/07 , A61K39/08 , A61K39/12 , A61K39/292 , A61K39/39 , A61K47/10 , A61K47/22 , A61K47/26 , A61K2039/543 , A61K2039/55566 , A61K2039/57 , A61K2039/70 , C12N2730/10134 , Y02A50/394 , Y02A50/403 , Y02A50/407 , Y02A50/464 , Y02A50/469 , Y02A50/472
摘要: The present invention provides methods and compositions for the stimulation of immune responses. Specifically, the present invention provides methods of inducing an immune response against one or a plurality of pathogens (e.g., vaccinia virus, H5N1 influenza virus, Bacillus anthracis, C. botulinum, Y. pestis, Hepatitis B, and/or HIV, etc.) in a subject (e.g., a human subject) and compositions useful in such methods (e.g., immunogenic composition comprising nanoemulsion and one or a plurality of pathogens (e.g., inactivated by the nanoemulsion) and/or pathogen products and/or pathogen components). Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination)) and research applications.
摘要翻译: 本发明提供了用于刺激免疫应答的方法和组合物。 具体地说,本发明提供诱导针对一种或多种病原体(例如痘苗病毒,H5N1流感病毒,炭疽芽孢杆菌,肉毒杆菌,鼠疫菌,乙型肝炎和/或HIV等)的免疫应答的方法。 )和可用于这些方法的组合物(例如,包含纳米乳剂和一种或多种病原体(例如,由纳米乳剂灭活)和/或病原体产物和/或病原体组分的免疫原性组合物) 。 本发明的组合物和方法尤其可用于临床(例如治疗和预防性药物(例如疫苗接种))和研究应用。
-
公开(公告)号:US08668911B2
公开(公告)日:2014-03-11
申请号:US13320205
申请日:2010-05-14
申请人: James R. Baker, Jr. , Paul E. Makidon , Whitney A. Dunlap , Jessica A. Knowlton , Benjamin Swanson
发明人: James R. Baker, Jr. , Paul E. Makidon , Whitney A. Dunlap , Jessica A. Knowlton , Benjamin Swanson
IPC分类号: A61K39/09
CPC分类号: A61K39/092 , A61K2039/521 , A61K2039/55566
摘要: The present invention provides methods and compositions for the stimulation of immune responses. In particular, the present invention provides immunogenic nanoemulsion compositions and methods of using the same for the induction of immune responses (e.g., innate and/or adaptive immune responses (e.g., for generation of host immunity against a bacterial species of the genus Streptococcus (e.g., Streptococcus pneumoniae))). Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination)) and research applications.
摘要翻译: 本发明提供了用于刺激免疫应答的方法和组合物。 特别地,本发明提供了免疫原性纳米乳剂组合物及其应用于诱导免疫应答的方法(例如,天然和/或适应性免疫应答(例如,用于产生针对链球菌属的细菌种的宿主免疫)(例如, ,肺炎链球菌)))。 本发明的组合物和方法尤其可用于临床(例如治疗和预防性药物(例如疫苗接种))和研究应用。
-
公开(公告)号:US08236335B2
公开(公告)日:2012-08-07
申请号:US11928447
申请日:2007-10-30
申请人: James R. Baker, Jr. , Tarek Hamouda , Amy Shih , Andrzej Myc
发明人: James R. Baker, Jr. , Tarek Hamouda , Amy Shih , Andrzej Myc
CPC分类号: A61K31/522 , A61K8/062 , A61K8/068 , A61K9/1075 , A61K31/14 , A61K45/06 , A61K2800/413 , A61Q17/005 , B82Y5/00 , Y02A50/393 , Y02A50/402 , Y02A50/463 , Y02A50/469 , Y02A50/471 , Y02A50/473 , Y02A50/475 , Y02A50/481 , Y10S514/937 , Y10S514/938 , A61K2300/00
摘要: The present invention relates to compositions and methods for decreasing the infectivity, morbidity, and rate of mortality associated with a variety of pathogenic organisms and viruses. The present invention also relates to methods and compositions for decontaminating areas colonized or otherwise infected by pathogenic organisms and viruses. Moreover, the present invention relates to methods and compositions for decreasing the infectivity of pathogenic organisms in foodstuffs.
摘要翻译: 本发明涉及用于降低与各种致病生物体和病毒有关的感染性,发病率和死亡率的组合物和方法。 本发明还涉及用于对由致病菌和病毒定殖或以其它方式感染的区域进行净化的方法和组合物。 此外,本发明涉及用于降低食品中病原生物体的感染性的方法和组合物。
-
公开(公告)号:US07474919B2
公开(公告)日:2009-01-06
申请号:US10637343
申请日:2003-08-08
IPC分类号: A61N1/30
CPC分类号: B82Y15/00 , A61B5/0095 , A61B8/481 , G01N21/718 , G01N29/2418 , G01N2291/02433 , G01N2291/02475 , G01N2291/02491
摘要: An additive, preferably in the form of metal nanoparticles or nanodomains, greatly improves a laser-based method and system for inducing optical breakdown. The use of ultrashort laser pulses to induce laser-induced breakdown (LIB) in metal nanoparticles or nanocomposites makes it possible to reduce significantly the threshold laser energy required for LIB. Such nanoscale (submicron) metallic particles allows one to control the LIB process. The nanoparticles can be synthesized so as to target specific biological structures or tissues (dendrimer nanoparticles are one system for which this has been demonstrated). This opens up the possibility of performing LIB for targeted cancer treatment or microsurgery.
摘要翻译: 优选以金属纳米颗粒或纳米域的形式的添加剂大大改进了用于诱导光学击穿的基于激光的方法和系统。 使用超短激光脉冲来诱导金属纳米颗粒或纳米复合材料中的激光诱发击穿(LIB)使得可以显着降低LIB所需的阈值激光能量。 这种纳米尺度(亚微米)金属颗粒允许控制LIB工艺。 可以合成纳米颗粒以靶向特定的生物结构或组织(树状聚合物纳米颗粒是已经证明其的一个体系)。 这开辟了进行靶向癌症治疗或显微手术的LIB的可能性。
-
30.
公开(公告)号:US07277169B2
公开(公告)日:2007-10-02
申请号:US11355387
申请日:2006-02-16
IPC分类号: G01N21/64
CPC分类号: G01J3/4406 , G01J3/10 , G01J3/2889 , G01N21/6408 , G01N21/6458
摘要: A fluorescence detection system for testing a sample having at least one fluorophore. The fluorescence detection system comprises a white light generation system outputting a white light pulse. The white light pulse has a first frequency range and a first time duration. The white light pulse excites the at least one fluorophore of the sample to emit a fluorescence. The fluorescence has a second frequency range and a second time duration, wherein the first time duration is less than the second time duration. A time-resolving detector receives the fluorescence and at least a portion of the white light pulse and separates the fluorescence from the portion of the white light pulse.
摘要翻译: 一种用于测试具有至少一个荧光团的样品的荧光检测系统。 荧光检测系统包括输出白光脉冲的白光发生系统。 白光脉冲具有第一频率范围和第一持续时间。 白光脉冲激发样品的至少一个荧光团以发射荧光。 荧光具有第二频率范围和第二持续时间,其中第一持续时间小于第二持续时间。 时间分辨检测器接收荧光和白光脉冲的至少一部分,并将荧光与白光脉冲的该部分分离。
-
-
-
-
-
-
-
-
-